title: The incidence and predictors of thromboembolic events in patients with lung cancer.
abstract: Patients with lung cancer experience elevated risk of venous thromboembolism. Cancer patients with thrombosis have a shorter life expectancy and the occurrence of VTE worsens the quality of life and may delay, interrupt, or completely halt the cancer therapy. In a large cohort of lung cancer patients we monitored the incidence of venous thromboembolism and we identified groups of patients with the highest risk of venous thromboembolism suitable for antithrombotic prophylaxis, which could favourably affect their morbidity and mortality.
authors.affiliation: Department of Respiratory Diseases and TB, Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic.
authors.forename: Bohdan
authors.identifier: 0000-0002-8725-8359
authors.initials: B
authors.lastname: Kadlec
authors.affiliation: Department of Respiratory Diseases and TB, Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic.
authors.forename: Jana
authors.initials: J
authors.lastname: Skrickova
authors.affiliation: Department of Respiratory Diseases and TB, Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic.
authors.forename: Zdenek
authors.initials: Z
authors.lastname: Merta
authors.affiliation: Institute of Biostatistics and Analyses, Faculty of Medicine and Faculty of Science, Masaryk University, Brno, Czech Republic.
authors.forename: Ladislav
authors.initials: L
authors.lastname: Dusek
authors.affiliation: Institute of Biostatistics and Analyses, Faculty of Medicine and Faculty of Science, Masaryk University, Brno, Czech Republic.
authors.forename: Jiri
authors.initials: J
authors.lastname: Jarkovsky
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005343:Fibrinolytic Agents; D006801:Humans; D015994:Incidence; D008175:Lung Neoplasms / Q000401:mortality* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000401:mortality* / Q000517:prevention & control
chemical_list: D005343:Fibrinolytic Agents